Dr. Denneny said that the OTC availability also allows an opportunity for more patient education on hearing loss, and the Academy is already preparing education materials to help patients navigate the system. He also encouraged otolaryngologists to be prepared to act as advocates for patient safety and appropriate treatment as these regulations are created.
